secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001640334-24-001537
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria raises $5M via registered direct offering and private placement of warrants
--------------------------------------------------------------------------------

- Gross proceeds of $5.0M from sale of 1,633,987 shares at $3.06/share plus 4,551,019 warrants exercisable at $3.06.
- Warrants exercisable only after stockholder approval; expire 5 years from approval date.
- Included cancellation of 2,917,032 outstanding warrants issued in April 2024.
- Net proceeds to be used for working capital and general corporate purposes.
- Placement agent H.C. Wainwright receives 7% cash fee and warrants for 57,190 shares at $3.825.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/0001640334-24-001537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer